Association between atherosclerosis and osteoporosis, the role of vitamin D

被引:63
作者
Stojanovic, Olivera Llic [1 ]
Lazovic, Milica [1 ]
Lazovic, Marko [2 ]
Vuceljic, Marina [3 ]
机构
[1] Inst Rehabil, Belgrade 11000, Serbia
[2] Clin Ctr Nis, Clin Cardiovasc Dis, Belgrade, Serbia
[3] Biochem Lab ALLABO, Belgrade, Serbia
关键词
vitamin D deficiency; low bone density; cardiovascular disease; fracture risk; BONE-MINERAL DENSITY; COA REDUCTASE INHIBITORS; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; D DEFICIENCY; AORTIC CALCIFICATION; LIPID PROFILE; FRACTURE RISK; LIPOPROTEIN; CALCIUM;
D O I
10.5114/aoms.2011.22066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The latest data support the correlation of atherosclerosis and osteoporosis, indicating the parallel progression of two tissue destruction processes with increased fatal and non-fatal coronary events, as well as higher fracture risk. Vitamin D inadequacy associated with low bone mineral density increases fall and fracture risk, leads to secondary hyperparathyroidism, calcifies coronary arteries and significantly increases cardiovascular disease. Randomized clinical trial evidence related to extraskeletal vitamin D outcomes was limited and generally uninformative. A recent recommendation on vitamin D dietary requirements for bone health is 600 IU/d for ages 1-70 years and 800 IU/d for 71 years and older, corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng/ml (50 nmol/l). Further large randomized controlled trials are needed to reassess laboratory ranges for 25-hydroxyvitamin D in both diseases, in order to avoid under- and over-treatment problems, and completely clarify the relationship between atherosclerosis and osteoporosis.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 82 条
[1]   Vascular calcification - Mechanisms and clinical ramifications [J].
Abedin, M ;
Tintut, Y ;
Demer, LL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1161-1170
[2]   Relationship between lipids and bone mass in 2 cohorts of healthy women and men [J].
Adami, S ;
Braga, V ;
Zamboni, M ;
Gatti, D ;
Rossini, M ;
Bakri, J ;
Battaglia, E .
CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (02) :136-142
[3]   Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol [J].
Adami, S ;
Braga, V ;
Guidi, G ;
Gatti, D ;
Gerardi, D ;
Fracassi, E .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) :599-604
[4]   Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? [J].
Anagnostis, P. ;
Karagiannis, A. ;
Kakafika, A. I. ;
Tziomalos, K. ;
Athyros, V. G. ;
Mikhailidis, D. P. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (02) :197-207
[5]   Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk? [J].
Anagnostis, Panagiotis ;
Athyros, Vasilios G. ;
Adamidou, Fotini ;
Florentin, Matilda ;
Karagiannis, Asterios .
CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (05) :720-730
[6]  
Askim M, 2001, Tidsskr Nor Laegeforen, V121, P2614
[7]   Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip [J].
Bagger, Y. Z. ;
Tanko, L. B. ;
Alexandersen, P. ;
Qin, G. ;
Christiansen, C. .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (06) :598-605
[8]  
Baldini V, 2005, J Endocrinol Invest, V28, P69
[9]   Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [J].
Bischoff-Ferrari, H. A. ;
Dawson-Hughes, B. ;
Staehelin, H. B. ;
Orav, J. E. ;
Stuck, A. E. ;
Theiler, R. ;
Wong, J. B. ;
Egli, A. ;
Kiel, D. P. ;
Henschkowski, J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :843
[10]   Positive association between 25-hydroxy, vitamin D levels and bone mineral density: A population-based study of younger and older adults [J].
Bischoff-Ferrari, HA ;
Dietrich, T ;
Orav, EJ ;
Dawson-Hughes, B .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (09) :634-639